The clinical utility of viral load monitoring in HIV infection: strengths and limitations.
作者信息
Erbelding E J, Quinn T C
出版信息
Genitourin Med. 1996 Dec;72(6):393-5. doi: 10.1136/sti.72.6.393.
Abstract
摘要
相似文献
1
The clinical utility of viral load monitoring in HIV infection: strengths and limitations.
Genitourin Med. 1996 Dec;72(6):393-5. doi: 10.1136/sti.72.6.393.
2
Reducing the risk of maternal-infant transmission of HIV by attacking the virus.
N Engl J Med. 1999 Aug 5;341(6):441-3. doi: 10.1056/NEJM199908053410609.
3
Maternal viral load and the risk of perinatal transmission of HIV-1.
N Engl J Med. 1999 Nov 25;341(22):1698-700. doi: 10.1056/NEJM199911253412215.
4
Dynamics of HIV-1 viral load in pregnancy.
AIDS. 1997 Sep;11(11):1397-8.
5
Maternal viral load and vertical transmission of HIV-1: an important factor but not the only one. The European Collaborative Study.
AIDS. 1999 Jul 30;13(11):1377-85.
6
Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
N Engl J Med. 1996 Nov 28;335(22):1621-9. doi: 10.1056/NEJM199611283352201.
7
The (viral) burden of motherhood.
GMHC Treat Issues. 1996 Apr;10(4):5-6.
8
Viral load affects risk for perinatal HIV transmission.
WORLD. 1999 Sep(No 101):6.
9
Vertical transmission of HIV in Ghanaian women diagnosed in cord blood and post-natal samples.
J Med Virol. 2005 Nov;77(3):351-9. doi: 10.1002/jmv.20463.
10
Reduced mother-to-child transmission of HIV associated with infant but not maternal GB virus C infection.
J Infect Dis. 2008 May 15;197(10):1369-77. doi: 10.1086/587488.
引用本文的文献
1
Can we predict the prognosis of HIV infection? How to use the findings of a prospective study.
Sex Transm Infect. 1998 Apr;74(2):149-54. doi: 10.1136/sti.74.2.149.
本文引用的文献
1
Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study.
JAMA. 1996 Jul 10;276(2):105-10.
2
HIV viral load markers in clinical practice.
Nat Med. 1996 Jun;2(6):625-9. doi: 10.1038/nm0696-625.
3
Prognosis in HIV-1 infection predicted by the quantity of virus in plasma.
Science. 1996 May 24;272(5265):1167-70. doi: 10.1126/science.272.5265.1167.
4
Viral dynamics of HIV: implications for drug development and therapeutic strategies.
Ann Intern Med. 1996 Jun 1;124(11):984-94. doi: 10.7326/0003-4819-124-11-199606010-00006.
5
Maternal plasma human immunodeficiency virus type 1 RNA level: a determinant and projected threshold for mother-to-child transmission.
Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12100-4. doi: 10.1073/pnas.92.26.12100.
6
Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1.
N Engl J Med. 1996 May 9;334(19):1222-30. doi: 10.1056/NEJM199605093341903.
7
8
Dynamics of viral replication in infants with vertically acquired human immunodeficiency virus type 1 infection.
J Clin Invest. 1996 Jan 15;97(2):323-30. doi: 10.1172/JCI118419.
9
Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS.
N Engl J Med. 1996 Feb 15;334(7):426-31. doi: 10.1056/NEJM199602153340703.
10
High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR.
Science. 1993 Mar 19;259(5102):1749-54. doi: 10.1126/science.8096089.
Zotero 插件